Silk-elastin-like hydrogel improves the safety of adenovirus-mediated gene-directed enzyme-prodrug therapy.

Recombinant silk-elastin-like protein polymers (SELPs) are well-known for their highly tunable properties on both the molecular and macroscopic hydrogel levels. One specific structure of these polymers, SELP-815K, has been investigated as an injectable controlled delivery system for the treatment of head and neck cancer via a gene-directed enzyme prodrug therapy (GDEPT) approach. Due to its pore size and gelation properties in vivo, SELP restricts the distribution and controls the release of therapeutic viruses for up to one month. It has been shown that SELP-mediated delivery significantly improves therapeutic outcome of the herpes simplex virus thymidine kinase (HSVtk)/ganciclovir (GCV) system in xenograft models of human head and neck cancer. However little is known about potential benefits of this approach with regard to toxicity in the presence of a fully intact immune system. The studies presented here were designed to assess the change in toxicity of the SELP-mediated viral delivery compared to free viral injection in a non-tumor-bearing immune competent mouse model. Toxicity was assessed at 1, 2, 4, and 12 weeks via body weight monitoring, complete blood count (CBC), and blood chemistry. It was found that in the acute and subacute phases (weeks 1-4) there is significant toxicity in groups combining the virus and the prodrug, and matrix-mediated gene delivery with SELP demonstrates a reduction in toxicity from the 2 week time point through the 4 week time point. At the end of the subchronic phase (12 weeks), signs of toxicity had subsided in both groups. Based on these results, recombinant SELPs offer a significant reduction in toxicity of virus-mediated GDEPT treatment compared to free virus injection in the acute and subacute phases.

[1]  Hamidreza Ghandehari,et al.  Controlled Release of Plasmid DNA from a Genetically Engineered Silk-Elastinlike Hydrogel , 2002, Pharmaceutical Research.

[2]  H. Ghandehari,et al.  Characterization of Structurally Related Adenovirus-laden Silk-elastinlike Hydrogels , 2008 .

[3]  H. Yamasaki,et al.  Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: role of gap-junctional intercellular communication. , 2000, Cancer research.

[4]  J. Cappello,et al.  In-situ self-assembling protein polymer gel systems for administration, delivery, and release of drugs. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[5]  M. Marquet,et al.  Genetic Engineering of Structural Protein Polymers , 1990, Biotechnology progress.

[6]  F. Yuan,et al.  A novel method for viral gene delivery in solid tumors. , 2005, Cancer research.

[7]  Hamidreza Ghandehari,et al.  Silk-elastinlike recombinant polymers for gene therapy of head and neck cancer: from molecular definition to controlled gene expression. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[8]  Hamidreza Ghandehari,et al.  Silk-elastinlike protein polymer hydrogels for localized adenoviral gene therapy of head and neck tumors. , 2009, Biomacromolecules.

[9]  H. Ghandehari,et al.  Genetically engineered silk-elastinlike protein polymers for controlled drug delivery. , 2002, Advanced drug delivery reviews.

[10]  M. Barry,et al.  Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[11]  J. G. Leslie,et al.  Elastin structure, biosynthesis, and relation to disease states. , 1981, The New England journal of medicine.

[12]  H. Ghandehari,et al.  Delivery of bioactive agents from recombinant polymers , 2007 .

[13]  M. Barry,et al.  Modification of adenoviral vectors with polyethylene glycol modulates in vivo tissue tropism and gene expression. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[14]  C. Napoli,et al.  Adenovirus Serotype 5 Hexon Mediates Liver Gene Transfer , 2008, Cell.

[15]  Hamidreza Ghandehari,et al.  Swelling behavior of a genetically engineered silk-elastinlike protein polymer hydrogel. , 2002, Biomaterials.

[16]  Hamidreza Ghandehari,et al.  Influence of polymer structure and biodegradation on DNA release from silk-elastinlike protein polymer hydrogels. , 2009, International journal of pharmaceutics.

[17]  S. G. Smith,et al.  The amino acid sequence in a fraction of the fibroin of Bombyx mori. , 1957, The Biochemical journal.

[18]  Yong Wang,et al.  Systemic dissemination of viral vectors during intratumoral injection. , 2003, Molecular cancer therapeutics.

[19]  A. Hatefi,et al.  Adenoviral Gene Delivery to Solid Tumors by Recombinant Silk–Elastinlike Protein Polymers , 2007, Pharmaceutical Research.

[20]  M. Haider,et al.  Molecular engineering of silk-elastinlike polymers for matrix-mediated gene delivery: biosynthesis and characterization. , 2005, Molecular pharmaceutics.

[21]  A. Cresce,et al.  Silk–elastinlike protein polymer hydrogels: Influence of monomer sequence on physicochemical properties , 2009 .

[22]  Hamidreza Ghandehari,et al.  In vitro and in vivo evaluation of recombinant silk-elastinlike hydrogels for cancer gene therapy. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[23]  D. Descamps,et al.  Two key challenges for effective adenovirus-mediated liver gene therapy: innate immune responses and hepatocyte-specific transduction. , 2009, Current gene therapy.

[24]  H. Laks,et al.  Efficiency, efficacy, and adverse effects of adenovirus vs. liposome-mediated gene therapy in cardiac allografts. , 2001, American journal of physiology. Heart and circulatory physiology.

[25]  Z. Ahmed,et al.  In vitro evaluation of a ‘stealth’ adenoviral vector for targeted gene delivery to adult mammalian neurones , 2009, The journal of gene medicine.

[26]  P. Stewart,et al.  Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo , 2008, Proceedings of the National Academy of Sciences.

[27]  Hamidreza Ghandehari,et al.  Silk‐elastinlike protein polymers improve the efficacy of adenovirus thymidine kinase enzyme prodrug therapy of head and neck tumors , 2010, The journal of gene medicine.